Covid 19 vaccine News
)
You must have seen those pictures when a person died due to cardiac arrest while working out in the gym. A person died due to heart failure while dancing to the DJ at a wedding. A person died suddenly while sitting on chair. After all, why are the youth dying suddenly? Various speculations are made regarding this. One of these speculations is that cases of sudden death have increased after taking the Corona vaccine? But now ICMR's study has answered this question.
)
During the Corona transition period, India was trying that foreign companies should also make vaccines in India so that the people of India could get the vaccine. Today in DNA, know why the Government of India did not buy the vaccine from abroad!
)
Another vaccine has been approved in the war against the corona epidemic. DCGI has approved Bharat Biotech's nasal vaccine for Corona. This will be the country's first nasal vaccine.
)
The country got a big success in the covid vaccination. There were 200 crore plus vaccine doses have been administered in the country. For a huge country like India, reaching this achievement in 18 months is very important. Zee News spoke to CVTF Chief Dr. Ek Arora on this big achievement.
)
The country got great success in covid vaccination. There were 200 crore plus vaccine doses in the country. India has got great success against Corona.
)
Vaccination camp to be held across 1 lakh centers, on June 12, 2022 by Tamil Nadu
1.64 crore people are yet to take the vaccine
List prepared to inoculate door-to-door campaign for the unvaccinated people of TN
)
If you have not vaccinated, then you must get it because according to a report, the people who have vaccinated are the safest at this time.
)
Children will get New Year's gift from January 3. To avoid Omicron, the first dose of vaccination will be taken
)
We are breaking our own record in the Corona Vaccination case, know how close we are to the record 100 crore figure.
)
Union Health Minister Mansukh Mandaviya released the first commercial batch of Covaxin from Bharat Biotech's new plant in Ankleshwar, Gujarat.
)
All India Majlis-e-Ittehadul Muslimeen (AIMIM) chief Asaduddin Owaisi on Sunday slammed the Center over the provision of vaccines to immunize citizens of India. He further said that another lie of the Modi government that Bharat Biotech will provide 7.60 crore vaccine doses from August to December has also been exposed.
)
The 'war of words' between Congress and BJP has intensified once again over the COVID vaccination program being run in India. Congress leader Rahul Gandhi tweeted that July has come but where is the vaccine. After this statement of Rahul Gandhi, now BJP has slammed the Congress party.
)
Gujarat-based pharmaceutical company Zydus Cadila has completed the Phase III trial of its coronavirus vaccine. Following which, the company has sought approval from the Drugs Controller General of India (DCGI) for emergency use of this drug on people above 12 years of age.
)
COVID-19 vaccine 'Covaxin' developed in India moves one more step closer to World Health Organization (WHO) approval. The global health body said on Tuesday that rolling data would start in July, following a pre-submission meeting with Bharat Biotech held on June 23.
)
On Tuesday, Delhi's All India Institute of Medical Sciences (AIIMS) began clinical trials of Bharat Biotech's Covaxin, India's first indigenously developed COVID-19 vaccine, on children aged 2-6 years.
)
The Union Health Ministry has issued new guidelines for pregnant women to get the COVID-19 vaccine and said that pregnancy does not increase the risk of infection. Like any medicine, a vaccine can have side effects that are usually mild.
)
In this special segment of Taal Thok Ke, we bring you a panel discussion on concurrent issues. In today's episode of 'Taal Thok Ke' we will discuss : 'Fake news factory' of Congress over vaccine?
)
Covaxin, the Coronavirus vaccine, maker Bharat Biotech on Tuesday said the price of Covaxin supplied to the Indian government at ₹150 per dose is a non-competitive price and is not sustainable in the long run and requires a higher price to offset part of the cost.
)
Pfizer said on Tuesday that it will begin testing its COVID-19 vaccine on a large group of children under the age of 12 after selecting a low dose of the shot in the first phase of testing. 4,500 children have been enrolled in 90 locations in some countries for the trial.
)
In this segment of Zee News, know the answer to every question regarding vaccination in India from Dr NK Arora, Chairman of COVID-19 Working Group, NTAGI.
Loading...
